Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects

about

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects

Item

http://www.wikidata.org/entity/Q59126269

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 26 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Pharmacokinetic and bioequival ...... suvastatin in healthy subjects

@en

Pharmacokinetic and bioequival ...... suvastatin in healthy subjects

@nl

type

Item

label

Pharmacokinetic and bioequival ...... suvastatin in healthy subjects

@en

Pharmacokinetic and bioequival ...... suvastatin in healthy subjects

@nl

prefLabel

Pharmacokinetic and bioequival ...... suvastatin in healthy subjects

@en

Pharmacokinetic and bioequival ...... suvastatin in healthy subjects

@nl

P1476

Pharmacokinetic and bioequival ...... suvastatin in healthy subjects

@en

P2093

Bo Kyung Kim

http://www.w3.org/2001/XMLSchema#string

Dong Heon Yang

http://www.w3.org/2001/XMLSchema#string

Eun Hee Kim

http://www.w3.org/2001/XMLSchema#string

Hae Won Lee

http://www.w3.org/2001/XMLSchema#string

Kyung-Tae Lee

http://www.w3.org/2001/XMLSchema#string

Mi-Ri Gwon

http://www.w3.org/2001/XMLSchema#string

Seungil Cho

http://www.w3.org/2001/XMLSchema#string

Sook Jin Seong

http://www.w3.org/2001/XMLSchema#string

Wang-Seob Shim

http://www.w3.org/2001/XMLSchema#string

Woo Youl Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Phenotype standardization for statin-induced myotoxicity

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.

Simultaneous determination of fimasartan, a novel antihypertensive agent, and its active metabolite in rat plasma by liquid chromatography-tandem mass spectrometry.

The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins.

Fimasartan, a novel angiotensin II receptor antagonist.

Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.

Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: a randomized, open-label, ascending single- and multiple-dose study.

A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers.

Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.

P304

3607-3615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S161917

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Boram Ohk

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30464392

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

P932

6208487

http://www.w3.org/2001/XMLSchema#string